The Future of Drug Discovery
By Kimberly Plessala. – On the topic of artificial intelligence, I for one, tend towards the Hollywood version. Where machines eventually deciding the human race is such an imperfect system fraught with disease and intellectual thresholds that the only sensible solution is to eliminate us. Back to reality, however IBM’s deployment of Watson in both patient care settings and now drug discovery efforts is most certainly elevating us to a new level.
IBM is launching the latest addition to the Watson family: Watson for Drug Discovery, which will use cognitive computing to help researchers zero in on new drug targets. First up is a collaboration with Pfizer, which will use the tech to boost its immuno-oncology research.